Visbiome
Visbiome is a pharmaceutical drug with 8 clinical trials. Currently 3 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
0.0%
0 of 2 finished
100.0%
2 ended early
3
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Probiotic Administration for Adolescent Depression
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
Probiotics in Newly Diagnosed T1D
Visbiome Effect on Colorectal Anastomosis and Local Recurrence
Impact of Probiotics on Drug, Vitamin, and Hormone Metabolism
Clinical Trials (8)
Probiotic Administration for Adolescent Depression
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
Probiotics in Newly Diagnosed T1D
Visbiome Effect on Colorectal Anastomosis and Local Recurrence
Impact of Probiotics on Drug, Vitamin, and Hormone Metabolism
Probiotic Visbiome for Inflammation and Translocation in HIV II
Probiotic Visbiome for Inflammation and Translocation in HIV Ι
Probiotic (Visbiome) for Gulf War Illness
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8